![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.155 | 3.43% | 4.675 | 4.35 | 5.00 | - | 25,623 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.52 | 9.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/4/2020 14:42 | Here we go up again | slinkyj | |
23/4/2020 14:36 | The risk from infected blood plasma umm aids hemophilia | ![]() bobaxe1 | |
23/4/2020 14:31 | Another big buy. Apr 23 2020, 14:23 63.887 70,000 63.00 64.00 Buy £44,720.9 | ![]() 2nell | |
23/4/2020 14:29 | Bootycall That's all well and good. However, SNG's Inhaled Intrferon B is to prevent the patient having to be put on a ventilator in the first place. Better that they don't deteriorate to ventilator stage by intervention with SNG's treatment first, which would remove the need for treatment afterward and remove the need for a ventilator completely. | ![]() jev1 | |
23/4/2020 14:25 | The two therapies that will beat Covid 19 in its most severe stage...triggering “cytokines storm” and death from ARDS ...are convalescent plasma and allogenic mesenchymal stem cells. The NIH is just starting a Randomised Controlled Study overseen by the Mount Sinai School of Medicine in NYC. The compassionate use of the latter therapy has had spectacular success in China, Iran, Israel, US and is championed by Prof Ellison Hughes of Kings College, London. The Welcome Foundation are sponsoring a similar type of cell trial in Belfast. In NYC the mortality rate of people put on a ventilator is 88% and for those over 65 it is 97%. In compassionate use trials, every person on mesenchymal stem cells, was taken off the ventilator. In NYC they were using a product called Remestemcel which has been given a priority review by the FDA and is likely to receive approval for paediatric GVHD in the next few months. The only reason i am posting today is that someone i respect, posted on another website about your stock. Hopefully he will read this and know that i do my research thoroughly. My coincidence is clear. I will not post here again unless asked. Good luck. | ![]() bootycall | |
23/4/2020 14:07 | https://www.proactiv | slinkyj | |
23/4/2020 14:05 | Ha anyone seen the proactive investor post today in the last 50 mins? Mentions Synairgen as one that has been priority labelled by the UK for fast track, previous news but has been re-confirmed today in this post which is more ++ news | slinkyj | |
23/4/2020 14:04 | From lse board..... | ![]() likya123 | |
23/4/2020 13:58 | Finster look at the average value of a block buster drug and you will get your answer it starts at in excess of £1 billion as the average cost of producing the drug which SNG have been able to trial at very low cost Phase 11 through phase 1V is frequently £500-700 million has been undertaken on an Orphan drug type agreement to acknowledge the dire need. | ![]() ant15 | |
23/4/2020 13:33 | Spread narrowing, movement north again | slinkyj | |
23/4/2020 13:32 | It will be interesting to see how high this can go without a) confirmation of success at trials and b) any commercial £££ deal for take to market I know this has so much potential for us to see a huge upside on current share price which will inflate the pre-trial result share price - but how far can it go on potential, regardless of how confident the market feels? I am looking forward to finding out... | ![]() finster007 | |
23/4/2020 13:30 | Couple of big sells out of the way | ![]() peachie 74 | |
23/4/2020 13:27 | Quick pullback then climb backup into close i expect. | ![]() cambradjones | |
23/4/2020 13:25 | Just some looking for a quick return. They do it on every share. They will be hoping it retraces then rinse and repeat. | ![]() russ42 | |
23/4/2020 13:23 | This is to close to ++ news to drop , this will test previous highs before the day is out and I expect set new highs | slinkyj | |
23/4/2020 13:23 | There just day trading after 10%. I take longer term punt only after 1000%, if it's more so be it | ![]() bobaxe1 | |
23/4/2020 13:23 | Good day so far. Bring on the results | ![]() imjustdandy | |
23/4/2020 13:15 | I feel bad saying it, but these people selling at 66 .... I really hope they can't get back in. FFS. Have they not done their homework...what more are they wanting from a product in terms of prospects!!!! | ![]() peachie 74 | |
23/4/2020 13:09 | Can see us having regular 20%+ days ahead. | ![]() cambradjones | |
23/4/2020 13:08 | some buying at ncyt today last hour be some fun to watch if usual buying seen last hour if buying trying to get if last hour rise and if rns tomorrow or end of trading | ![]() bunz3 | |
23/4/2020 13:06 | Lol this is IMM fever all over again. Deja vu is strong today. | ![]() spawny100 | |
23/4/2020 13:06 | That's a few profit takers out the way. You can't blame them, But that the buying starting again. | ![]() russ42 | |
23/4/2020 13:04 | my Bad.... | torreskid | |
23/4/2020 12:58 | Don't do a disservice skid, think GLOBAL | ![]() d1nga | |
23/4/2020 12:57 | RM mentions preparing for the other paradigm of therapy which will target the 'vulnerable' at home, and therein lies the huge potential of using this as a prophylactic/early therapeutic intervention 6.6 million have Asthma or copd in UK | torreskid |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions